Compounds for the Treatment of Hepatitis C

A compound of formula I

• where
• R1 is alkyl, hydroxyalkyl, alkoxyalkyl, haloalkyl, cycloalkyl, hydroxycycloalkyl, alkoxycycloalkyl, halocycloalkyl, cycloalkenyl, benzyl, indanyl, or alkylcarbonyl;
• R2 is hydrogen, cyano, halo, alkyl, haloalkyl, alkoxy, or haloalkoxy;
• R3 is hydrogen, alkyl, (amino)alkyl, (alkylamino)alkyl, (dialkylamino)alkyl, ((alkylcarbonyl)amino)alkyl, ((haloalkylcarbonyl)amino)alkyl, ((alkoxycarbonyl)amino)alkyl, ((benzyloxycarbonyl)amino)alkyl, alkylcarbonyl, alkoxycarbonyl, benzyloxycarbonyl, aminocarbonyl, alkylaminocarbonyl, or dialkyaminocarbonyl;
• R4 is hydrogen, alkyl, (amino)alkyl, (alkylamino)alkyl, or (dialkylamino)alkyl;
• R5 is hydrogen, alkyl, (amino)alkyl, (alkylamino)alkyl, or (dialkylamino)alkyl;
• R6 is pyrollidinyl, piperidinyl, or piperazinyl and is substituted with 0-3 substituents selected from alkyl, alkylcarbonyl, alkoxycarbonyl, and benzyloxycarbonyl;
• Q is an alkylene or alkenylene chain containing 0-6 groups selected from the group consisting of O, NR3, S, S(O), S(O2), C(O)O, C(O)NR4, OC(O)NR4, NR4C(O)NR4, and Z, provided that any O or S atom does not directly bond to another O or S atom, such that ring A is 12-31 membered;
• and where the alkylene or alkenylene chain is substituted with 0-6 substituents selected from the group consisting of alkyl, hydroxy, alkoxy, R6, (R6)alkyl, and phenyl where the phenyl substituent is further substituted with 0-4 substituents selected from cyano, halo, alkyl, haloalkyl, alkoxy, and haloalkoxy;
• X is O, CH2, CO, CO2, or C(O)NR5;
• and
• Z is C3-7 cycloalkylene, phenylene, pyrrolidindiyl, piperidindiyl, or piperazindiyl;
• or a pharmaceutically acceptable salt thereof.